Trial for 10-minute oesophageal cancer sponge test commences

Individuals who routinely use medication for heartburn are being invited to participate in the concluding phase of a screening trial for oesophageal cancer, which employs a 10-minute sponge examination. Participants will be instructed to ingest a dissolvable capsule on a string. This capsule releases a sponge, comparable in size to a 50p coin, designed to gather cells from the oesophagus as it is withdrawn. Should the trial prove successful, this method has the potential to be integrated into the UK NHS cancer screening initiative. Professor Rebecca Fitzgerald of the University of Cambridge stated: “Catching [cancer] earlier can save lives by reducing the need for chemotherapy and surgery to remove the oesophagus.” This initiative, valued at £6.4 million and aiming to enroll 120,000 participants, receives joint financial backing from Cancer Research UK and the National Institute for Health and Care Research. Oesophageal cancer can manifest in any part of the oesophagus, also referred to as the gullet or food pipe. The capsule sponge, also identified as the pill-on-a-thread, offers a rapid and straightforward test for Barrett’s oesophagus, a condition potentially preceding cancer. The sponge is ingested, its outer layer dissolves upon reaching the stomach, and it is subsequently carefully retrieved via the string, gathering cells for analysis in a laboratory. Paul Anderson, a 59-year-old stock controller residing in St Neots, Cambridgeshire, was among the initial individuals to take part in the trial. He expressed his hope that it will “give me some more insight into my chronic heartburn, as well as helping people who may have similar concerns about their health”. Professor Fitzgerald, who serves as the director of the university’s Early Cancer Institute, commented that this technique is “changing how we detect Barrett’s oesophagus and oesophageal cancer”. It is anticipated that this test could preserve lives and lessen the necessity for “labour-intensive” endoscopy – a procedure involving a camera inserted down the throat – which Cancer Research UK identifies as the present “gold standard” for diagnosing and treating this specific cancer. The organization reported approximately 9,300 new instances of oesophageal cancer annually in the UK, positioning it as the nation’s seventh most frequent cause of cancer-related fatalities. The BEST4 Screening trial is accessible to men aged over 55 and women aged over 65 who are already receiving treatment for chronic heartburn, with invitations to be dispatched via text message by the NHS. This research is spearheaded by Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge. For updates on Cambridgeshire news, follow BBC Sounds, Facebook, Instagram, and X. Copyright 2024 BBC. All rights reserved. The BBC bears no responsibility for the content found on external websites. Information regarding our policy on external linking is available.